FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:1215-1222 March 24, 2005 Number 12 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the authors' clinical recommendations.

Six weeks ago, a 45-year-old woman noticed a scratchy feeling in her throat that has now progressed to more than 20 episodes of severe, spasmodic coughing per day. Her coughing spells are worse at night and are sometimes associated with gagging and vomiting. Her adolescent son and several of his friends, who received all of their childhood immunizations on schedule, had similar . . . [Full Text of this Article]

The Clinical Problem

Clinical Presentation and Complications

Epidemiology, Incidence, and Burden of Disease

Strategies and Evidence

Diagnostic Methods

Treatment

Prophylaxis after Exposure

Prevention

Areas of Uncertainty

Guidelines

Conclusions and Recommendations

Source Information

From the Division of Infectious Diseases and International Health, Departments of Medicine and Pharmacology, University of Virginia School of Medicine, Charlottesville (E.L.H.); and the Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville (K.M.E.).

Address reprint requests to Dr. Hewlett at P.O. Box 800419, University of Virginia School of Medicine, Charlottesville, VA 22908, or at eh2v@virginia.edu.

This article has been cited by other articles:

• Cortese, M. M., Baughman, A. L., Zhang, R., Srivastava, P. U., Wallace, G. S. (2008). Pertussis Hospitalizations Among Infants in the United States, 1993 to 2004. Pediatrics 121: 484-492 [Abstract] [Full Text]  
• Fishbein, D. B., Broder, K. R., Markowitz, L., Messonnier, N. (2008). New, and Some Not-so-New, Vaccines for Adolescents and Diseases They Prevent. Pediatrics 121: S5-S14 [Abstract] [Full Text]  
• Eidlitz-Markus, T., Mimouni, M., Zeharia, A. (2007). Pertussis Symptoms in Adolescents and Children Versus Infants: The Influence of Vaccination and Age. CLIN PEDIATR 46: 718-723 [Abstract]  
• Carbonetti, N. H., Artamonova, G. V., Van Rooijen, N., Ayala, V. I. (2007). Pertussis Toxin Targets Airway Macrophages To Promote Bordetella pertussis Infection of the Respiratory Tract. Infect. Immun. 75: 1713-1720 [Abstract] [Full Text]  
• Lin, Y.-C., Yao, S.-M., Yan, J.-J., Chen, Y.-Y., Chiang, C.-S., Wu, H.-S., Li, S.-Y. (2007). Epidemiological shift in the prevalence of pertussis in Taiwan: implications for pertussis vaccination. J Med Microbiol 56: 533-537 [Abstract] [Full Text]  
• Easley, C. J., Karlinsey, J. M., Bienvenue, J. M., Legendre, L. A., Roper, M. G., Feldman, S. H., Hughes, M. A., Hewlett, E. L., Merkel, T. J., Ferrance, J. P., Landers, J. P. (2006). A fully integrated microfluidic genetic analysis system with sample-in-answer-out capability. Proc. Natl. Acad. Sci. USA 103: 19272-19277 [Abstract] [Full Text]  
• Singh, M., Lingappan, K. (2006). Whooping cough: the current scene.. Chest 130: 1547-1553 [Abstract] [Full Text]  
• Spensieri, F., Fedele, G., Fazio, C., Nasso, M., Stefanelli, P., Mastrantonio, P., Ausiello, C. M. (2006). Bordetella pertussis Inhibition of Interleukin-12 (IL-12) p70 in Human Monocyte-Derived Dendritic Cells Blocks IL-12 p35 through Adenylate Cyclase Toxin-Dependent Cyclic AMP Induction.. Infect. Immun. 74: 2831-2838 [Abstract] [Full Text]  
• Pichichero, M. E., Blatter, M. M., Kennedy, W. A., Hedrick, J., Descamps, D., Friedland, L. R. (2006). Acellular Pertussis Vaccine Booster Combined With Diphtheria and Tetanus Toxoids for Adolescents. Pediatrics 117: 1084-1093 [Abstract] [Full Text]  
• Watanabe, M., Connelly, B., Weiss, A. A. (2006). Characterization of serological responses to pertussis.. CVI 13: 341-348 [Abstract] [Full Text]  
• Committee on Infectious Diseases, (2006). Prevention of Pertussis Among Adolescents: Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine. Pediatrics 117: 965-978 [Abstract] [Full Text]  
• Jimbo, M. (2005). Antibiotic Prescribing for Lower Respiratory Tract Infection. JAMA 294: 3089-3090 [Full Text]  
• Donato, G. M., Hsia, H.-L. J., Green, C. S., Hewlett, E. L. (2005). Adenylate Cyclase Toxin (ACT) from Bordetella hinzii: Characterization and Differences from ACT of Bordetella pertussis. J. Bacteriol. 187: 7579-7588 [Abstract] [Full Text]  
• Cherry, J. D. (2005). Pertussis Vaccines for Adolescents and Adults. Pediatrics 116: 755-756 [Full Text]  
• Preston, A. (2005). Bordetella pertussis: the intersection of genomics and pathobiology. CMAJ 173: 55-62 [Abstract] [Full Text]